NGNA compositions and methods of use
US11672814B2 · kind B2 · utility
0Cited by
6References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2020 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Jul 16, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/0618
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of viral disorders, and in particular to the use of natural compounds to inhibit viruses and viral infection. Compositions comprising NGNA are provided for treating or preventing viral infections, such as those causing the common cold.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.